Gram-negative Burkholderia cepacia complex (Bcc) isolates were screened for antimicrobial activity against cystic fibrosis microbial pathogens, and the ability of B. ambifaria to inhibit B. multivorans was identified. The activity was mapped to a cluster of cryptic, quorum-sensing-regulated modular polyketide synthase (PKS) genes. Enacyloxin IIa and its stereoisomer designated iso-enacyloxin IIa were identified as metabolic products of the gene cluster, which encoded an unusual hybrid modular PKS consisting of multiple proteins with sequence similarity to cis-acyltransferase (cis-AT) PKSs and a single protein with sequence similarity to trans-AT PKSs. The discovery of the potent activity of enacyloxins against drugresistant bacteria and the gene cluster that directs their production provides an opportunity for engineered biosynthesis of innovative enacyloxin derivatives and highlights the potential of Bcc bacteria as an underexploited resource for antibiotic discovery.
INTRODUCTION
Bacteria within the Gram-negative genus Burkholderia are well known for their phenotypic and genotypic diversity (Coenye and Vandamme, 2003) . The Burkholderia cepacia complex (Bcc) is a subgroup of closely related Burkholderia species that reflect this functional multiplicity by demonstrating biopesticidal interactions at the plant rhizosphere (Parke and GurianSherman, 2001 ), a capacity for the bioremediation of aromatic hydrocarbon pollutants (Chain et al., 2006; O'Sullivan et al., 2007) , and also the ability to cause devastating lung infections in individuals with cystic fibrosis (CF) . The taxonomy of B. cepacia complex isolates has undergone extensive revision over the last decade, with expansion from 1 to 17 formally named Bcc species Vanlaere et al., 2009 ). All Bcc bacteria possess intrinsic resistance to a range of antimicrobial compounds including antibiotics and biocides (Rose et al., 2009) , and infections in patients with CF are difficult to treat with currently available antibiotics (Chernish and Aaron, 2003) . Outside of CF infection, the rhizosphere is the best-characterized environmental habitat of Bcc bacteria (Parke and Gurian-Sherman, 2001) , where their biopesticidal ability to protect crops from fungal and nematodal pathogens has been linked in part to their ability to biosynthesize a range of antibiotic or toxic secondary metabolites (Parke and Gurian-Sherman, 2001; Vial et al., 2007) .
Antifungal antibiotics known to be produced by Bcc species include cepacin, cepaciamide, xylocandins, quinolinones, phenylpyrroles, and phenazines (Parke and Gurian-Sherman, 2001; Vial et al., 2007 ). An antifungal nonribosomally biosynthesized lipopeptide, AFC-BC11, has been genetically characterized in B. cepacia strain BC11 (Kang et al., 1998) , and the recently described Burkholdines 1097 and 1229 are antifungal cyclic lipopeptides produced by B. ambifaria 2.2N (Tawfik et al., 2010) . One of the most well known Bcc antibiotics is pyrrolnitrin, a broad-range antifungal phenylpyrrole that has been recently found to be produced by several Bcc species under the control of quorum sensing (QS) (Schmidt et al., 2009) . Burkholderia secondary metabolites may also have multiple functions, such as the 4-quinolinones which were originally characterized as antifungal antibiotics and plant growthpromoting agents (Moon et al., 1996) , and more recently derivatives such as 2-heptyl-3-hydroxy-4(1H)-quinolone have also been shown to act as a quorum-sensing signal in B. ambifaria and other non-Bcc Burkholderia species (Diggle et al., 2006; Vial et al., 2008) . Several studies have demonstrated that non-Bcc Burkholderia species are capable of producing polyketide antibiotics such as the rhizoxin toxin which causes rice blight (Partida-Martinez and Hertweck, 2007) , the bactobolins which have antibacterial activity (Seyedsayamdost et al., 2010) , and the food-related toxin bronkrecic acid (Rohm et al., 2010) . In addition to the identification of antimicrobials naturally produced by Burkholderia bacteria, Knappe et al. (2008) used a genomemining approach to isolate capistruin, a lasso peptide encoded by the B. thailandensis genome. Bioinformatic analysis of the ketosynthase (KS) domains of trans-acyltransferase (AT) polyketide synthase (PKS)-encoding genes also enabled the identification of thailandamide polyketides within the B. thailandensis genome and their subsequent biological analysis (Nguyen et al., 2008) .
Given the extent to which the taxonomic description of Bcc species has changed and the limited number of antibiotics characterized in well-defined Burkholderia species (Schmidt et al., 2009; Seyedsayamdost et al., 2010; Tawfik et al., 2010; Vial et al., 2007) , we performed a systematic survey of antimicrobial activity across a large collection of genetically typed Bcc strains. In addition, because it has been anecdotally observed that CF sputum appears less polymicrobial once chronic infection with a Bcc isolate is established, we also specifically screened for Bcc antagonism toward other CF pathogens such as Pseudomonas aeruginosa, Staphylococcus aureus, the yeast Candida albicans, as well as other Bcc species (Lipuma, 2010) . A broad range of antimicrobial Bcc phenotypes was observed, the most remarkable of which was the activity against multidrug-resistant (MDR) Gram-negative bacteria shown by B. ambifaria, a species previously known for its antifungal and biopesticidal properties (Coenye et al., 2001) . Using transposon mutagenesis, we mapped the genes responsible for the antibacterial activity to a putative polyketide biosynthesis island within the genome of B. ambifaria AMMD, and together with global gene expression identified multiple accessory loci required for antibiotic biosynthesis. Purification and spectroscopic analysis of the compounds responsible for the anti-Gram-negative activity identified them as enacyloxins (Watanabe et al., 1982) , unusual polyene antibiotics that target protein biosynthesis by inhibition of the ribosomal elongation factor Tu . LC-MS analyses confirmed that enacyloxin production was abolished in the transposon mutants. Sequence comparisons of the enzymes encoded by genes within the enacyloxin biosynthetic gene cluster suggest a complete hypothetical pathway for enacyloxin biosynthesis involving an extremely unusual hybrid PKS composed of proteins with sequence similarity to both the phylogenetically distinct cis-AT and trans-AT PKS families (Piel, 2010) , several PKS modules with sequence similarity to cis-AT proteins that lack AT domains, a unique mechanism for polyketide chain release, and both nonheme iron-and flavin adenine dinucleotide (FAD)-dependent chlorinases. The enacyloxins appear to be one of an armory of antimicrobial compounds synthesized by B. ambifaria, and the mapping of their biosynthetic pathway reflects the remarkable diversity of antimicrobial functions that can be acquired and expressed by these versatile bacteria.
RESULTS
Prevalence of Antimicrobial Activity within the Bcc An initial screen for antimicrobial activity was performed on nine genome-sequenced Bcc strains and nine other representative isolates (see Experimental Procedures). To stimulate secondary metabolite production, Bcc bacteria were (1) grown on a minimal medium containing glycerol, a carbon source that often promotes antibiotic production (Keum et al., 2009 ); (2) incubated for 5 days such that stationary phase was reached; and (3) grown as a dense single colony where biofilm-and quorumsensing interactions could promote alternative metabolism and catabolism (see Experimental Procedures). After growth, the Bcc strains were overlaid with B. multivorans and a zone of clearing was observed around the B. ambifaria AMMD colony ( Figure 1A ). The demonstration of novel anti-Gram-negative activity in B. ambifaria was expanded to a systematic screen of 268 Bcc isolates, comprising 13 named species and 5 novel subgroups within the complex (Table 1) ; 228 of these isolates were genetically distinct strains by multilocus sequence typing (MLST) , and the collection possessed a similar number of isolates from clinical infections (43%) and from the natural environment (57%). Antimicrobial activity against a panel of CF pathogens including Gram-negative bacteria (P. aeruginosa and B. multivorans), Gram-positive bacteria (S. aureus), and fungi (C. albicans) was examined (Table 1) .
No antagonism toward P. aeruginosa was observed; however, 32% of the Bcc isolates demonstrated anticandidal properties and 24% were capable of inhibiting the growth of S. aureus (Table 1) The results of a B. ambifaria strain AMMD antimicrobial screening assay are shown for overlays with three multidrug-resistant bacteria in (A): Bm, B. multivorans C1576 (Glasgow outbreak strain); Bd, B. dolosa LMG 18943 (Boston outbreak strain); and Ab, A. baumannii OXA23 clone 2. The antimicrobial phenotypes of wild-type B. ambifaria strain AMMD, a rapid secretor mutant (11-8-2), and two PKS mutants within the biosynthesis island (21-7-2 and 9-11-5) are shown against overlays of B. multivorans (Bm), S. aureus (Sa), and C. albicans (Ca) in (B). The gene inactivated by the transposon insertion is shown in brackets (see Table 2 ). The figure comprises a composite of proportionately cropped images of overlay assays, and a scale bar of 10 mm is shown in each panel to indicate the size of the zone of antimicrobial inhibition. See also Figures S1 and S2.
with greater than 29% of isolates in each species producing inhibition zones; the same Bcc species were also highly antagonistic toward C. albicans (Table 1) (Table 1) . Anti-Gram-negative activity was not common in the Bcc (Table 1) ; however, six B. ambifaria isolates strongly inhibited the growth of B. multivorans (Figure 1) , and the genome-sequenced species-type strain for B. ambifaria, strain AMMD (Coenye et al., 2001 ) (see http://www.burkholderia.com) was selected for further study of this novel activity.
B. ambifaria Produces an Antimicrobial Active on Other Bcc Bacteria B. ambifaria AMMD inhibited the growth of all B. multivorans (n = 11) and B. dolosa (n = 7) strains tested. Notably, the AMMD antimicrobial was also active against pan-resistant Gram-negative strains such as the B. multivorans Glasgow CF strain (Rose et al., 2009) , B. dolosa Boston CF strain (Kalish et al., 2006) , and Acinetobacter baumannii OXA23 clone 2 (Coelho et al., 2006) (Figure 1A) . B. cepacia, B. cenocepacia, B. stabilis, B. vietnamiensis, B. ambifaria, B. lata Figure 1B ) were identified and mapped to the AMMD genome (Table 2 ). Four transposon insertions mapped to chromosome 1 (Table 2) : mutations within general secretory pathway genes either stopped BAMM production or reduced it; mutation of a type I glycosyltransferase within an exopolysaccharide gene cluster gave a BAMM-negative phenotype; and transposon insertion into an AraC-type transcriptional regulator coding sequence (CDS) resulted in early onset of BAMM secretion (a zone of clearing was seen after 18 hr). The same rapid secretion phenotype was seen with mutation of a cation diffusion facilitator family transporter gene (Bamb_5056, mutant 11-8-2) encoded on chromosome 2 (Table 2) , which also demonstrated greater anticandidal activity than the wild-type ( Figure 1B ). Five independently isolated BAMM-negative mutants mapped to the same locus on chromosome 2, a hypothetical gene, Bamb_5367, adjacent to a recombination hot spot (RHS) element, Bamb_5366, encoding a valine-glycine-rich protein (VGR) protein. Another interesting chromosome 2 mutation which stopped BAMM secretion was 
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Enacyloxin Biosynthesis in B. ambifaria that of Bamb_4118 (two independent mutants; Table 2), a homolog of the acyl homoserine lactone (AHL) synthase, CepI, associated with Gram-negative QS systems (Malott et al., 2005) . The lack of BAMM secretion in the cepI mutant suggested that QS plays an integral role in activating antibiotic biosynthesis correlating to the stationary phase growth onset of BAMM secretion.
Nine mutants mapped to the same region on chromosome 3, a large genomic island (87.4 kb; coordinates 392535-479734) with a 71.5% GC content compared to the 66.5% GC average for this B. ambifaria AMMD replicon. The island spanned 33 coding sequences (Bamb_5910-5943; see Table S1 available online for function and homology data). Several CDSs encoded proteins with similarity to known modular PKSs, suggesting the BAMM antimicrobial was a polyketide (Nguyen et al., 2008; Zerikly and Challis, 2009) . The organization of the 24 genes within the island is shown in Figure 2 . Transposon mutations resulting in a BAMM-negative phenotype were mapped to four of the seven PKS CDSs ( Figure 2 and Table 2 ). Transposon insertions mapped to a type II thioesterase (proposed in other systems to maintain PKS activity by catalyzing hydrolysis of aberrant intermediates that block procession of the growing polyketide chain along the PKS), and FADH 2 -dependent chlorinase upstream of these genes also abrogated BAMM production (Table 2 and Figure 2 ). Downstream of the PKS genes and at the far end of the genomic island were two genes encoding putative LuxR-type regulators, one of which, Bamb_5910, was mapped by a transposon insertion which resulted in a BAMMnegative phenotype. Because mutation of the Bamb_4118 AHL synthase had also prevented BAMM secretion, it was not surprising to find that mutation of a LuxR regulator within the island stopped production of the antimicrobial.
Transposon inactivation of the PKS genes ( Figure 2 ) resulted in mutants that produce no zones of inhibition in the B. multivorans overlay assays (data shown for the Bamb_5925 and Bamb_5919 mutants, 21-7-2 and 9-11-5, respectively, in Figure 1B ). These PKS mutants still produced a zone of inhibition against S. aureus, although the activity was weaker than the wild-type ( Figure 1B) . Interestingly, the anticandidal activity of B. ambifaria AMMD was unaffected by mutation of the PKS genes ( Figure 1B ), suggesting 
Enacyloxin Biosynthesis in B. ambifaria that the polyketide antibiotic being produced from the PKS cluster had limited antifungal activity as detected by the colony overlay assay. None of the transposon mutants demonstrated increased susceptibility to the AMMD polyketide when they were themselves overlaid onto a wild-type B. ambifaria AMMD colony, indicating that the genes identified as essential for BAMM production (Table 2) did not play a role in self-resistance to the secreted antimicrobial. PCR primers designed to detect three PKS-encoding genes, Bamb_5925, Bamb_5921, and Bamb_5919 (Figure 2 ), amplified the corresponding loci from five other B. ambifaria strains (BCC0118, BCC0203, BCC0250, BCC0480, and BCC1254) that also demonstrated BAMM activity (Table 1 ). The positive bioactivity and presence of homologous genes spanning the PKS region suggested that all these B. ambifaria isolates possessed a functional BAMM polyketide biosynthesis island even though each was a genetically distinct strain by MLST.
Isolation and Structure Elucidation of the Metabolic Product of the Cryptic BAMM Polyketide Biosynthetic Gene Cluster Adsorption of the presumed polyketide product of the conserved genomic island onto XAD-16, a neutral crosslinked polystyrene resin that adsorbs erythromycin from solution (Ribeiro and Ribeiro, 2003) , was investigated as an initial step in the isolation of the BAMM activity. Active methanol eluates were obtained from adsorption of the supernatants of liquid cultures and aqueous washes of the agar from solid-medium growth of B. ambifaria AMMD (see Experimental Procedures). The eluates obtained from agar-grown bacteria proved most stable, and LC-MS analysis indicated that they contained several compounds. The eluates were therefore further fractionated by semipreparative HPLC, and each fraction was analyzed by high-resolution electrospray ionization mass spectrometry (HR-ESI-MS).
One fraction afforded ions with m/z = 256.1694 and 258.1848 ( Figure S1 ). The molecular formulas deduced for these ions (calculated for C 17 H 22 NO + : 256.1696, and for C 17 H 24 NO + : 258.1852) correspond to 2-(2-heptenyl)-3-methyl-4-quinolinone and 2-heptanyl-3-methyl-4-quinolinone, respectively ( Figure S1 ), known antifungal agents originally isolated from ''Pseudomonas cepacia'' strain PCII (Moon et al., 1996) (the taxonomic status of this Bcc isolate is not known). MS/MS analyses indicated that these compounds contain a common 3-methyl-4-quinoline core and a heptenyl/heptyl side chain, respectively (Vial et al., 2008) . B. ambifaria has previously been reported to produce these molecules as quorum-sensing signals (Vial et al., 2008) , suggesting that these Burkholderia secondary metabolites may play multiple roles. The B. ambifaria AMMD genome contains a corresponding 2-alkyl-3-methyl-4-quinolinone biosynthetic gene cluster, hmqA-G (Bamb_5763-5769), on chromosome 3 approximately 166 kb downstream of the BAMM polyketide biosynthesis island.
Another fraction afforded an ion with m/z = 702.2446. This corresponds to the molecular formula of the known polyketide antibiotic enacyloxin IIa (calculated for C 33 H 46 NO 11 Cl 2 + : 702.2442) (Watanabe et al., 1992 ). This fraction also had an The arrangement of 24 genes within the polyketide biosynthesis island is shown as three panels, each drawn to the scale given by the bars on the right of each respective panel. The functional contribution of each gene to polyketide biosynthesis is shown by the color-coded key, and genes mapped by transposon mutagenesis (see Table 2 ) are indicated. All genes in the pathway shown above were significantly upregulated under antibiotic-inducing growth conditions (see Table S4 ) except Bamb_5913 (*). Homology data to support the putative function of each gene are provided in Table S1 , with the microarray demonstrating upregulation of the gene cluster during enacyloxin production-inducing growth conditions provided in Table S4 .
Enacyloxin Biosynthesis in B. ambifaria absorbance maximum at 360 nm in the UV/vis spectrum, consistent with the polyene chromophore of the enacyloxins. Subsequent LC-MS analysis of chloroform extracts from B. ambifaria AMMD agar-grown cultures identified two, presumably isomeric, compounds with the same molecular formula as enacyloxin IIa. These compounds were purified by semipreparative HPLC. NMR spectroscopic analysis of the compounds identified them as enacyloxin IIa (Watanabe et al., 1992) and its novel D-4,5-Z stereoisomer, which we have named iso-enacyloxin IIa (Figure 3 ; Tables S2 and S3 ). LC-MS analyses of XAD-16 eluates from the mutants containing transposon insertions within the Tables S2 and S3. cryptic PKS gene cluster (21-7-2, Bamb_5925 and 9-11-5, Bamb_5919; Figures 1B and 2 ) indicated that they did not contain enacyloxins (Figure 3 ), unequivocally linking enacyloxin biosynthesis to this novel biosynthetic island. The 4-quinolinone metabolites ( Figure S1 ) could still be detected by LC-MS in the XAD-16 eluates of the mutants, correlating with the retained anticandidal properties of the mutants ( Figure 1B ).
Antimicrobial Spectrum of the B. ambifaria Enacyloxins Antibiotic susceptibility testing (Table 3) was performed on enacyloxin IIa and iso-enacyloxin IIa purified from B. ambifaria. These experiments demonstrated that both had novel and highly potent activity against B. multivorans, B. dolosa, and A. baumannii, all of which are considered pan-resistant Gram-negative pathogens. Enacyloxin IIa was approximately twice as active as iso-enacyloxin IIa (Table 3) , suggesting that the change in the configuration of the 4,5-double bond in iso-enacyloxin IIa either reduces its ability to penetrate these pathogens or, more likely, alters its ability to bind to its target, the elongation factor Tu . P. aeruginosa and B. cenocepacia were both resistant to the maximum concentration tested (100 mg/l). The purified enacyloxins also lacked inhibitory activity against C. albicans at 100 mg/l, correlating with the observation that the PKS gene mutants retained their normal anticandidal phenotype ( Figure 1B ).
Sequence Analysis of the Enacyloxin Biosynthetic Gene Cluster
Comparisons of the sequences of the proteins encoded by CDSs within the genomic island on chromosome 3 with proteins of known function identified 21 genes hypothesized to be involved in enacyloxin biosynthesis (Figure 2 ). Bamb_5925-5920 all encode proteins with similarity to so-called cis-AT modular PKSs, in which each module contains an AT domain for loading
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Enacyloxin Biosynthesis in B. ambifaria of the starter or extender unit onto the adjacent acyl carrier protein (ACP) domain ( Figure 4A ). Further analysis of each of these proteins using PKS and conserved domain search programs (Marchler-Bauer and Bryant, 2004; Yadav et al., 2003) showed that they constitute a loading module and nine chain-extension modules ( Figure 4A ).
The proposed structure of the intermediate assembled on the module 9 ACP domain (including the stereochemistry of the hydroxyl groups and the branching methyl group predicted using the method of Keatinge-Clay, 2007) ( Figure S3 ) corresponds closely to the C-3 to C-23 portion of the polyketide chain of the proposed structure of enacyloxin IVa, a known intermediate in the biosynthesis of enacyloxin IIa in Frateuria sp. W-135 (Furukawa et al., 2007) . The ACP-bound intermediate lacks the chloro groups attached to C-11 and C-18, the hydroxyl group attached to C-14, and the carbamoyl group attached to the C-19 hydroxyl group of enacyloxin IVa. These functional groups are proposed to be introduced by on-PKS or post-PKS tailoring reactions (vide supra). D-4,5 in the enacyloxin IVa polyketide chain is missing in the predicted structure of the intermediate attached to the module 9 ACP domain, because module 9 lacks the ketoreductase (KR) domain required to reduce the b-keto group to the corresponding hydroxyl group, which would be subsequently eliminated by the dehydratase (DH) domain to afford the double bond (Figure 4) . Perhaps reduction of this keto group and subsequent elimination of water is catalyzed by the KR and DH domains within module 10 of the PKS. This might explain why a mixture of enacyloxin IIa isomers with D-4,5 geometries is produced by B. ambifaria. Interestingly, module 6 appears to be lacking a DH domain that would be expected to be required for introduction of D-10,11 into the intermediate attached to the ACP domain of module 10. Presumably, the dehydration reaction required to introduce this double bond is catalyzed by the module 7 DH domain. The final discrepancy between the predicted structure of the intermediate attached to the module 9 ACP domain and the proposed structure of enacyloxin IVa is between the absolute stereochemistry of C-15 proposed for enacyloxin IVa and the corresponding stereocenter in the intermediate (Figure 4) . A recent ''J-resolved HMBC-1'' analysis of enacyloxin IVa (Furukawa et al., 2007) suggested that it has 15S absolute stereochemistry, whereas the corresponding stereocenter in the intermediate is predicted on the basis of the hypothetical stereospecificity of the module 4 KR domain to have the 15R configuration (Keatinge-Clay, 2007) . Further experiments will be needed to resolve this discrepancy.
An unusual feature of modules 2-5 and 7-9 is that they lack the AT domains invariably found within conventional cis-AT PKSs. No other genes within the cluster encode ATs, suggesting that the AT domain(s) within module 1 and/or module 6 catalyzes in trans loading of malonyl-CoA extender units onto the ACP domains within the AT-less PKS modules, as well as in cis loading of malonyl-CoA extender units onto the ACP domains within their own modules. Alternatively, loading of malonyl-CoA onto the ACP domains within the AT-less modules could be catalyzed by an acyltransferase encoded by a gene lying outside the enacyloxin biosynthetic gene cluster. A GCN5-related N-acetyltransferase (GNAT)-like domain within the loading module is hypothesized to catalyze decarboxylation of methylmalonylCoA and subsequent transfer of the resulting propionyl-CoA starter unit onto the adjacent ACP domain. Methylmalonyl-CoA is a novel substrate for GNAT domains within loading modules, which hitherto have only been reported to utilize malonyl-CoA (Gu et al., 2007) .
Bamb_5919 encodes a protein that is similar to so-called trans-AT modular PKSs (Table 2) , a group of proteins that is phylogenetically distinct from the cis-AT PKSs and in which the modules lack an AT domain for loading of the starter/extender unit onto the adjacent ACP domain, relying instead on separately encoded acyltransferases that load starter/extender units (usually malonyl-CoA) onto the ACP domains (Piel, 2010) . Thus, the enacyloxin assembly line represents only the second example of a modular PKS that contains a mixture of proteins belonging to both the cis-AT and trans-AT phylogenetic groups (Piel, 2010) . The other example is the kirromycin PKS, which consists mostly of proteins with similarity to trans-AT PKSs, but the last protein within the PKS portion of the assembly shows sequence similarity to cis-AT PKSs (Weber et al., 2008) . Interestingly, kirromycin and enacyloxins have the same target-elongation factor Tu (EF-Tu) . As expected for trans-AT PKSs, the protein encoded by Bamb_5919, which constitutes the last module of the enacyloxin PKS, lacks an AT domain (Figure 4 ). The lack of any genes encoding stand-alone ATs within the gene cluster suggests that the AT domain(s) within module 1 and/or module 6 of the enacyloxin PKS is responsible for loading malonyl-CoA onto the ACP domain within this protein. Alternatively, malonyl-CoA could be loaded onto the ACP domain by an AT encoded by a gene that lies outside the enacyloxin biosynthetic gene cluster. Four genes within the genome encoded AT domains with significant homology to Bamb_5925 and Bamb_5921; in order of decreasing homology these were Bamb_6476, Bamb_6235, Bamb_6222, and Bamb_0998. Only Bamb_6476 (an amino acid adenylation domain-containing protein; 15.37-fold upregulation) and Bamb_0998 (a malonyl CoA-acyl carrier protein transacylase; 2.24-fold upregulation) were expressed under enacyloxin-inducing conditions, but both at a level considerably below that of the pathway genes Bamb_5925 and Bamb_5921 (Table 2) .
Release of the fully assembled polyketide chain from modular PKSs normally involves macrocyclization or hydrolysis catalyzed Note that the order of the tailoring reactions may be different from that shown and may occur during polyketide chain assembly rather than after. The structure for enacyloxin IVa proposed by Furukawa et al. (2007) on the basis of NMR experiments is shown in the box. The discrepancy in the absolute stereochemistry of C-15 between this structure and that predicted for enacyloxin IVa by the ketoreductase stereospecificity model of Keatinge-Clay (2007) is highlighted by stereochemical descriptors; an alignment of ketoreductase domains to support this stereospecificity is provided in Figure S3 .
(B) Proposed pathway for biosynthesis of DHCCA from 5-dehydroshikimate. B. ambifaria CDS numbers are shown in blue.
Enacyloxin Biosynthesis in B. ambifaria by a thioesterase domain at the C terminus of the last PKS module. The C-terminal domain within the last module of the enacyloxin PKS is a so-called ketosynthase 0 (KS 0 ) domain (Figure 4) . Such domains are common within trans-AT PKSs and are proposed to catalyze transacylation of intermediates in polyketide assembly from one ACP domain to another (Piel, 2010) . We propose that the KS 0 domain within module 10 of the enacyloxin PKS catalyzes transfer of the fully assembled polyketide chain from the module 10 ACP domain to an ACP domain within the protein encoded by Bamb_5917. Bamb_5915 encodes a protein that is similar to nonribosomal peptide synthetase condensation domains that is proposed to catalyze condensation of the C-3 hydroxyl group of (1S, 3R, 4S)-3,4-dihydroxycyclohexane carboxylic acid (DHCCA) with the thioester, to effect polyketide chain release via an unusual mechanism (Kö nig et al., 1997), forming pre-enacyloxins. DHCCA is proposed to be biosynthesized from shikimate, an intermediate in aromatic amino acid biosynthesis by the enzymes encoded by Bamb_5916, Bamb_5914, Bamb_5912, and Bamb_5918 ( Figure 4) . A putative shikimate dehydrogenase encoded by Bamb_5913 may boost the levels of shikimate for DHCCA biosynthesis by reduction of 5-dehydroshikimate. The pre-enacyloxins are proposed to be converted to decarbamoyl-enacyloxin IVa and iso-decarbamoyl-enacyloxin IVa by the action of a putative FADH 2 -, O 2 -, and chloride-dependent halogenase (Blasiak and Drennan, 2009 ) which chlorinates C-11, a putative a-ketoglutarate-, O 2 -, chloride-, and putative nonheme iron-dependent chlorinase (Blasiak and Drennan, 2009 ) which chlorinates C-18, and an a-ketoglutarate-, O 2 -, and nonheme iron-dependent dioxygenase (Singh et al., 2008) which hydroxylates C-14, encoded by Bamb_5928, Bamb_ 5931, and Bamb_5927, respectively (Figure 4) . Carbamoylation of decarbamoyl-enacyloxins IVa to give enacyloxin IVa and iso-enacyloxin IVa is likely catalyzed by the putative carbamoyltransferase (Xu et al., 2002) encoded by Bamb_5930. The conversion of enacyloxin IVa to enacyloxin IIa in Frateuria sp. W-315 has been shown to be catalyzed by enacyloxin oxidase, an extracellular pyrroloquinoline quinone (PQQ)-dependent enzyme with an estimated molecular mass of 73 kDa (Oyama et al., 1994) . Bamb_5932 encodes a putative 71.6 kDa PQQdependent enzyme that is proposed to catalyze the similar conversion of enacyloxins IVa to enacyloxins IIa in B. ambifaria.
Expression Analysis of B. ambifaria Genes Involved in Secondary Metabolite Biosynthesis
To map the genes that contribute to the biosynthesis of the enacyloxins on a global scale, a comparison of B. ambifaria AMMD gene expression after growth to stationary phase on glycerol (a carbon source inducing its production) versus glucose was performed using a custom microarray designed to the B. ambifaria AMMD genome. Over half the protein-encoding CDSs in B. ambifaria AMMD were significantly altered in expression (1.5-fold change, p < 0.05) by growth on glycerol (3405/6635; 51% of the genomic CDSs), with 2032 CDSs upregulated and 1373 CDSs downregulated (see Supplemental Information; ArrayExpress experiment accession number E-MEXP-2819). Nineteen of the 22 gene loci implicated in BAMM biosynthesis by transposon mutagenesis were significantly altered in expression (Table 2) , corroborating the performance of the AMMD custom microarray, a platform which has also been extensively validated on B. cenocepacia (Drevinek et al., 2008) . Six gene clusters associated with the production of secondary metabolites were significantly upregulated, with the enacyloxin island and region encoding the AfcA lipopeptide (Kang et al., 1998) both having an atypical GC content indicative of acquisition by horizontal gene transfer (Table S4) .
Genes within the enacyloxin biosynthesis island were among the most highly upregulated when B. ambifaria AMMD was grown to stationary phase on glycerol, with alterations ranging from 1.6-to 292-fold (Table S4 ). All the genes proposed to be involved in the biosynthesis of enacyloxin (Figures 2 and 4) were significantly upregulated, except for Bamb_5913, a putative shikimate dehydrogenase hypothesized to supply 5-dehydroshikimate for DHCCA biosynthesis (Figure 4 ; Table S4 ). The interconversion of shikimate and 3-dehydroshikimate is a step in the shikimate pathway for aromatic amino acid biosynthesis. Thus, Bamb_5913 appears to be redundant, which might explain why its expression is not upregulated under conditions that induce enacyloxin production. An efflux gene of the multidrug and toxin extrusion family (MATE), Bamb_5933, was also upregulated 102-fold, suggesting that it may provide the self-resistance pathway for enacyloxin. Both orphan LuxR regulators (Bamb_5910 and 5911) were also upregulated (Table S4) , corroborating all the previous evidence showing that enacyloxin biosynthesis was under QS control.
Three other gene clusters correlating the biosynthesis of known Bcc antifungal antibiotics were also highly expressed (Table S4) : the pyrrolnitrin biosynthetic gene cluster prnA-D (Bamb_4726-4729) (Schmidt et al., 2009) , the 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS)/4-hydroxy-3-methyl-2-alkylquinoline (HMAQ) biosynthetic gene cluster hmqA-G (Bamb_5763-5769) (Diggle et al., 2006; Vial et al., 2008) , and a cluster of 26 genes (Bamb_6128-6153; only Bamb_6149 was not significantly upregulated) within which Bamb_6150 encoded a protein that was homologous to AfcA implicated in the biosynthesis of an antifungal lipopeptide from ''P. cepacia'' (Kang et al., 1998 ) (a Bcc isolate of unknown species). Both pyrrolnitrin ( Figure S2 ) and the HMAQs ( Figure S1 ) were detected in the Amberlite resin eluates from B. ambifaria AMMD, correlating the expression of these gene clusters to secondary metabolite secretion. The AFC lipopeptide appeared not to be present in these extracts. In addition, two further gene clusters, Bamb_3597-3617 and Bamb_6468-6482, predicted to direct the production of novel cryptic secondary metabolites, were also significantly overexpressed (Table S4) .
DISCUSSION

B. ambifaria Enacyloxin Activity on MDR Pathogens and Other Burkholderia
We have demonstrated that Bcc bacteria can antagonize the growth of a range of clinically important pathogens associated with CF (Lipuma, 2010) and other multidrug-resistant infections (Coelho et al., 2006) , in addition to their well-known antifungal biological control abilities in the natural environment (Parke and Gurian-Sherman, 2001 ). The ability of B. ambifaria to inhibit MDR Gram-negative bacteria such as B. multivorans, B. dolosa, and A. baumannii by secretion of enacyloxin IIa
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Enacyloxin Biosynthesis in B. ambifaria and its novel isomer iso-enacyloxin is remarkable, especially as the susceptible Burkholderia species all belong to a taxonomically closely related complex (Coenye and Vandamme, 2003; Mahenthiralingam et al., 2005) . Whereas antagonism toward fungi and Gram-positive bacteria has been observed in historical studies of either single isolates or limited collections of Bcc bacteria (Schmidt et al., 2009; Seyedsayamdost et al., 2010; Tawfik et al., 2010) , the ability of B. ambifaria to inhibit the growth of closely related intrinsically antibiotic-resistant Bcc species is significant. The only other Burkholderia antimicrobial described that has significant activity on another Burkholderia species is the capistruin peptide of B. thailandensis, which is active on B. caledonica (Knappe et al., 2008) .
Because a large proportion of Bcc isolates screened (Table 1 ) produced antimicrobial activity against C. albicans and S. aureus, which are also common CF pathogens (Lipuma, 2010) , our laboratory-based observation lends weight to the hypothesis that infection with Bcc bacteria can reduce the polymicrobial content of sputum. B. ambifaria itself is not a common CF pathogen, reflecting less than 3% of all Bcc CF infections seen in the United States (Lipuma, 2010) . However, it is a common environmental Bcc species (Coenye et al., 2001; Ramette et al., 2005) . Two of the six enacyloxin-positive B. ambifaria isolates were recovered from infected CF patients, with the rest being of environmental origin. Given the limited number of CF infections caused by enacyloxin-positive B. ambifaria strains, determining whether the antibiotic is actually secreted during CF infection will not be straightforward. B. cenocepacia, which is the second most common Bcc CF infection (31% of cases; Lipuma, 2010) , possesses significant anticandidal and anti-Gram-positive activity (Table 1) . Thus, after identification of these antimicrobial metabolites, screening for their presence in CF sputum could be more readily performed.
Quorum Sensing and Accessory Loci Are Required for Enacyloxin Secretion
The quorum-sensing-regulated secretion of the enacyloxins by B. ambifaria is in agreement with the finding that multiple other Burkholderia antimicrobial secondary metabolites such as pyrrolnitrin (Schmidt et al., 2009) , bactobolin (Seyedsayamdost et al., 2010) , and thailandamide (Ishida et al., 2010) also require this form of cell-to-cell bacterial communication for their production. Although multiple LuxRI-type QS systems may occur in certain Bcc species such as B. cenocepacia (Malott et al., 2005) , B. ambifaria AMMD only encodes the Bamb_4118 CepI synthase homolog and an adjacent CepR homolog (Bamb_4116) as the classical, putatively ancestral QS arrangement seen within the Bcc (Malott et al., 2005) . The enacyloxin biosynthesis island encodes two LuxR-type orphan regulators, Bamb_5910 and Bamb_5911, which are upregulated by 4-fold (Table 2 ) and 11-fold (see Supplemental Information), respectively, during antibiotic secretion. Transposon mutation of Bamb_5910 (Table 2 and Figure 2 ) abolishes enacyloxin secretion; however, the insertion may have disrupted expression of both tandemly arranged luxR homologs. Therefore, although this mutant phenotype clearly links enacyloxin production to QS regulation, further work will be required to define how each luxR homolog functions to modulate B. ambifaria gene expression. Both QS regulator genes reside within the enacyloxin biosynthesis genomic island, illustrating the unique capacity for Burkholderia bacteria to acquire, regulate, and express large, complex foreign gene clusters. In addition to its QS requirement, enacyloxin production is also carbon source dependent, suggesting further complexity in antibiotic regulation. Overall, these findings suggest that future screening of Burkholderia species for antimicrobial secondary metabolites should take into account both metabolic factors and regulatory systems such as QS dependency.
Although the enacyloxin biosynthesis island appeared to be relatively self-contained encoding the biosynthetic enzymes (e.g., PKS modules Bamb_5919-5952) as well as regulators (e.g., LuxR-type regulators Bamb_5910 and Bamb_5911) and putative self-resistance proteins (e.g., the MATE efflux protein Bamb_5933), the mutagenesis and global gene expression data also implicated multiple accessory loci in enacyloxin secretion. In the context of novel biological functions being linked to microbial genes, one of the most intriguing genes identified was the hypothetical gene Bamb_5367, which is located on an RHSgenetic locus of chromosome 2. Five independent transposon mutations mapped to Bamb_5367, suggesting this region was integral to enacyloxin secretion (Table 2) . RHS loci have been linked to type VI secretion systems, and recent bioinformatic analyses of these VGR proteins indicate that they may evolve function by acquisition and switching of alternate C-terminal sequences or tips (Jackson et al., 2009) . Our data suggest that there is a novel link to enacyloxin export for this B. ambifaria RHS-VGR locus. Although all the transposon mutations in this region mapped to Bamb_5367, significant upregulation of this gene was not detected (Table 2) . However, both Bamb_5366 and Bamb_5368 were significantly upregulated during enacyloxin biosynthesis (2.3-and 1.7-fold, respectively; see Supplemental Information), corroborating the involvement of the RHS locus in antibiotic export and suggesting that Bamb_5368 may act as an alternative C terminus for Bamb_5366. The high GC content of the PKS genes (Bamb_5919 to 5925 had a mean GC content of 74.5%; Table S4) within the enacyloxin biosynthesis island suggests the cluster may have originated in an actinomycete. The novel involvement of RHS loci in enacyloxin secretion suggests that after acquisition of the biosynthesis island, B. ambifaria had to tailor antibiotic secretion to suite its Gram-negative physiology, illustrating the versatility of Burkholderia in assembling and expressing complex metabolic pathways (Chain et al., 2006) .
Enacyloxin Biosynthesis and Its Manipulation to Produce Novel Antibiotics
To date, enacyloxins have only been reported to be produced by a single bacterial isolate, Frateuria sp. W-315, a Gammaproteobacterium of the family Xanthomonadaceae (Furukawa et al., 2007) . Apart from the PQQ-dependent oxidation reaction that converts enacyloxin IVa to enacyloxin IIa (Oyama et al., 1994) , nothing is known about enacyloxin biosynthesis in Frateuria. The discovery of enacyloxin IIa and its novel stereoisomer isoenacyloxin IIa as the metabolic products of a cryptic modular polyketide synthase biosynthetic gene cluster in B. ambifaria has allowed a plausible pathway for enacyloxin biosynthesis to be proposed. This hypothetical pathway involves several unusual or unique features, including only the second example of a hybrid
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Enacyloxin Biosynthesis in B. ambifaria PKS consisting of proteins with sequence similarity to both cis-AT and trans-AT variants, novel methylmalonyl-CoA specificity for a GNAT-like domain within a PKS loading module, condensation domain-mediated polyketide chain release via intermolecular ester bond formation, a novel route for DHCCA biosynthesis from shikimate, regiospecific chlorination of a polyene catalyzed by a flavin-dependent chlorinase (only aromatic rings have been reported to be chlorinated by such enzymes to date), and stereospecific hydrocarbon chlorination by a nonheme ironand a-ketoglutarate-dependent chlorinase. Remarkably, only two of the nine PKS chain-extension modules with sequence similarity to cis-AT proteins appear to contain AT domains, and no stand-alone ATs are encoded by genes within the enacyloxin biosynthetic gene cluster. This suggests that the ACP domains within the seven PKS modules that are similar to cis-AT proteins, but lack AT domains, are loaded with malonyl extender units either by the two modules containing AT domains or by an AT encoded by a gene lying outside the enacyloxin biosynthetic gene cluster (although no candidate for this additional AT was identified in the transposon mutagenesis experiments, and homology searches only revealed two candidate AT-containing genes expressed under enacyloxin-inducing conditions).
The antibacterial activity of enacyloxins stems from their ability to inhibit protein synthesis by binding to EF-Tu, which locks the protein in the GTP-bound conformation (regardless of whether GTP or GDP is bound), preventing release of aminoacyl-tRNA after delivery to the acceptor site of the ribosome . Interestingly, the expression of multiple ribosomal and regulatory RNAs is upregulated during enacyloxin biosynthesis (see Supplemental Information), suggesting that their overproduction may contribute to the enacyloxin resistance in B. ambifaria. The X-ray crystal structure of enacyloxin IIa bound to a complex of EF-Tu with a nonhydrolyzable GTP analog pinpoints important functional groups in the antibiotic that interact with the elongation factor. This information coupled with the proposed pathway for enacyloxin biosynthesis should stimulate future biosynthetic engineering efforts to produce novel enacyloxin analogs with potential applications in the treatment of MDR Gram-negative infections.
SIGNIFICANCE
Gram-negative B. cepacia complex bacteria are known for their ability to secrete a range of antifungal secondary metabolites that contribute to their biopesticidal phenotype. Bcc bacteria also cause human opportunistic infections in individuals with CF. However, it is not known whether they can antagonize the growth of other pathogens which infect the lungs of these individuals. Recent revisions in Bcc taxonomy and our curiosity about the ability of Bcc bacteria to compete with other CF pathogens stimulated us to perform a systematic survey of Bcc antimicrobial secretion. Of 268 representative Bcc isolates screened, 85 were antifungal, 64 were anti-Gram positive, and 6 B. ambifaria isolates inhibited a range of multidrug-resistant (MDR) Gram-negative bacteria including the CF pathogen B. multivorans. Using transposon mutagenesis and global gene expression analysis, production of the B. ambifaria antibacterial was mapped to a cluster of cryptic, quorumsensing-regulated genes within the genome of B. ambifaria strain AMMD, several of which encode proteins that are similar to modular polyketide synthases (PKSs). Isolation and structure elucidation demonstrated that the antibiotic was a mixture of enacyloxin IIa, an unusual polyene targeting elongation factor Tu, and a stereoisomer we designated isoenacyloxin IIa. Sequence analysis of the proteins encoded within the enacyloxin biosynthetic gene cluster allowed a complete hypothetical pathway for enacyloxin biosynthesis to be proposed. This pathway involves several distinctive features including a very unusual hybrid cis-acyltransferase (cis-AT)/trans-AT PKS consisting of a loading module containing a GCN5-related N-acetyltransferase domain that appears to be specific for methylmalonyl-CoA, nine chain-extension modules with sequence similarity to cis-AT PKSs (seven of which lack AT domains), and a single AT-less chain-extension module with sequence similarity to trans-AT PKSs. These findings suggest that the Bcc may be an underexploited resource for the discovery of antibiotics with distinctive biosynthetic pathways and potent activity against MDR pathogens.
EXPERIMENTAL PROCEDURES Strains and Culture Conditions
All Burkholderia isolates were drawn from previous studies and had been accurately identified to the species level by either MLST or recA sequence analysis (Payne et al., 2005) . Genome-sequenced Bcc strains used were as follows: B. lata 383, B. multivorans ATCC 17616, B. ambifaria AMMD, B. ambifaria MC40-6, B. vietnamiensis G4, B. cenocepacia J2315, B. cenocepacia HI2424, B. cenocepacia AU1054, and B. cenocepacia IIIB MC0-3, with sequence data available at the Burkholderia Genome Database (http://www.burkholderia. com), and B. contaminans LMG 23255, for which the Burkholderia SAR-1 metagenome serves as a reference sequence (Mahenthiralingam et al., 2006 C) was carried out on tryptic soya medium, whereas production of antibiotics was performed on a minimal salts medium with 4 g/l glycerol as the carbon source (BSM-G; O'Sullivan et al., 2007) . Antibiotic susceptibility testing was carried out using a standardized broth microdilution assay (Rose et al., 2009 ) with a maximum concentration of 100 mg/l enacyloxin tested.
Antimicrobial Activity Screens A classical overlay assay was used to screen for antimicrobial activity (see Supplemental Information). Briefly, each Bcc strain was grown as a single colony on BSM-G agar, killed with chloroform vapor after growth, and overlaid with soft Isosensitest agar (Oxoid) seeded with a susceptibility-testing reference species. Antimicrobial activity was scored by measuring the zone of clearing (mm) around the Bcc colony; in the initial screen of the Bcc collection isolates, those producing a zone of clearing greater than 10 mm were scored as positive for antimicrobial activity (Table 1) .
Transposon Mutagenesis and Genome Mapping B. ambifaria strain AMMD was subjected to transposon mutagenesis with mini-Tn5-Km2 as described (O'Sullivan et al., 2007) and a bank of 1920 mutants was created. Mutants were screened for reduction, loss of, and increased activity against B. multivorans ATCC 17616 using the overlay assay. The loci flanking the transposon insertions were sequenced (O'Sullivan et al., 2007) and correlated to the B. ambifaria AMMD genome using the web database http://www.burkholderia.com.
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